Balbous Anaïs, Cortes Ulrich, Guilloteau Karline, Rivet Pierre, Pinel Baptiste, Duchesne Mathilde, Godet Julie, Boissonnade Odile, Wager Michel, Bensadoun René Jean, Chomel Jean-Claude, Karayan-Tapon Lucie
INSERM1084, Laboratoire de Neurosciences Expérimentales et Cliniques, Poitiers, F-86021, France.
Université de Poitiers, U1084, Poitiers, F-86022, France.
BMC Cancer. 2016 Aug 5;16:604. doi: 10.1186/s12885-016-2647-9.
Radioresistant glioblastoma stem cells (GSCs) contribute to tumor recurrence and identification of the molecular targets involved in radioresistance mechanisms is likely to enhance therapeutic efficacy. This study analyzed the DNA damage response following ionizing radiation (IR) in 10 GSC lines derived from patients.
DNA damage was quantified by Comet assay and DNA repair effectors were assessed by Low Density Array. The effect of RAD51 inhibitor, RI-1, was evaluated by comet and annexin V assays.
While all GSC lines displayed efficient DNA repair machinery following ionizing radiation, our results demonstrated heterogeneous responses within two distinct groups showing different intrinsic radioresistance, up to 4Gy for group 1 and up to 8Gy for group 2. Radioresistant cell group 2 (comprising 5 out of 10 GSCs) showed significantly higher RAD51 expression after IR. In these cells, inhibition of RAD51 prevented DNA repair up to 180 min after IR and induced apoptosis. In addition, RAD51 protein expression in glioblastoma seems to be associated with poor progression-free survival.
These results underscore the importance of RAD51 in radioresistance of GSCs. RAD51 inhibition could be a therapeutic strategy helping to treat a significant number of glioblastoma, in combination with radiotherapy.
耐辐射胶质母细胞瘤干细胞(GSCs)导致肿瘤复发,鉴定参与辐射抗性机制的分子靶点可能会提高治疗效果。本研究分析了来自患者的10个GSC系在电离辐射(IR)后的DNA损伤反应。
通过彗星试验对DNA损伤进行定量,并通过低密度阵列评估DNA修复效应器。通过彗星试验和膜联蛋白V试验评估RAD51抑制剂RI-1的效果。
虽然所有GSC系在电离辐射后均显示出有效的DNA修复机制,但我们的结果表明,在两个不同的组中存在异质性反应,显示出不同的内在辐射抗性,第1组高达4Gy,第2组高达8Gy。耐辐射细胞组2(10个GSC中有5个)在IR后显示出显著更高的RAD51表达。在这些细胞中,RAD51的抑制在IR后长达180分钟阻止了DNA修复并诱导了细胞凋亡。此外,胶质母细胞瘤中RAD51蛋白表达似乎与无进展生存期差有关。
这些结果强调了RAD51在GSCs辐射抗性中的重要性。RAD51抑制可能是一种治疗策略,有助于与放疗联合治疗大量胶质母细胞瘤。